KBT & Schematerapi SG AB
ActiveKey figures
Key figures
2025Summary: KBT & Schematerapi SG AB
What kind of company is it?
KBT & Schematerapi SG AB (org. no. 559236-5679) is a limited company (AB). The company was registered in 2020 and has existed for 6 years. Registered seat: Stockholm. Industry according to Statistics Sweden: tertiary education (SNI 85400).
How is the company doing financially?
Net sales in financial year 2025 were 742 000 kr, up 21,2 % on the previous year (612 000 kr). From 2022 to 2025, net sales declined by an average of 5,9 % per year. Financial year 2025 ended with a loss of 439 507 kr. The company was profitable in 3 of the 4 reported financial years. At the end of financial year 2025, total assets were 1 310 903 kr and equity 1 090 000 kr (equity ratio 83,1 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. The LEI code (984500P8Z25075C04S28) comes from the GLEIF database. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 204 325 kr.
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Sales revenue | 890 000 | 954 000 | 612 000 | 742 000 |
| Profit for the reporting year | 552 228 | 666 245 | 297 408 | −439 507 |
| Retained earnings of previous periods | — | — | — | — |
| Total assets | 1 636 748 | 2 076 699 | 2 505 000 | 1 310 903 |
| Total liabilities | 476 774 | 445 480 | 771 373 | 220 903 |
| Total equity | 1 159 974 | 1 631 219 | 1 733 627 | 1 090 000 |
| Employees | — | — | — | — |
| Proposed dividend | — | — | 204 325 | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.